$REPL Cantor takeaways: why I didn’t buy the dip
• Early sales will likely look weak by design: starter dose is ~1/10 the maintenance-dose economics, and management expects a gradual first ~6 months.
• Bigger concern is real-world treatment intensity. Management acknowledged